Chronic diseases account for a major share of healthcare needs and spending. Economic evaluation helps identify interventions that create the most value over time.
Decisions that unfold over the long term
Diabetes, cancers, cardiovascular diseases, respiratory diseases, and chronic conditions require decisions that go beyond the immediate cost of treatment.
Benefits may emerge years later through avoided complications, improved quality of life, reduced hospital use, or preserved productivity.
Prevention, treatment, and follow-up should be compared
Economic evaluation can compare very different strategies: screening, prevention, early management, intensive treatment, reinforced follow-up, or therapeutic innovation.
It helps identify where investment produces the greatest impact and in which populations an intervention is most relevant.
Budget impact remains central
Even when an intervention is efficient, scaling it up may represent a significant cost for health systems. Budget impact analysis anticipates this pressure and tests multiple implementation scenarios.
It is particularly useful for national programs, ministry decisions, and large-scale prevention strategies.
Avoided costs should be documented with caution
In chronic diseases, an intervention may generate savings by reducing complications, hospitalizations, consultations, or loss of autonomy. But these savings are not always immediate and are not always captured by the same payer.
A credible analysis distinguishes short-term avoided costs, delayed benefits, and broader gains for patients, families, or society.
Quality of life is a major outcome
Chronic diseases are not only about mortality or clinical events. They affect fatigue, autonomy, anxiety, ability to work, family life, and social participation.
Integrating quality of life into economic evaluation helps better represent the real value of an intervention, especially when benefits are gradual or diffuse.
Better orienting health policy
In chronic diseases, economic evaluation helps shift the discussion from expenditure to health investment.
Santicxis supports institutions, organizations, and partners seeking to prioritize interventions, document their value, and prepare affordable decisions.